Ardian acquires Biofarma from White Bridge
Private equity firm Ardian has taken a majority stake in Biofarma Group, an Italian manufacturer of neutraceuticals, from Milan-based sponsor White Bridge Investments.
More on Buyouts
Goldman Sachs AM beats sponsors to buy Norgine
Buyer's PE arm competed with Bain and Cinven in the auction second round
Perusa to exit Müpro in SBO to IK
Management of the German industrial fixings supplier will reinvest with a minority stake
Ufenau acquires EinzelNet in first deal with Fund VII
Management and founders will retain a 25% stake in the Spanish IT services group; bolt-ons planned under new owner
MB Funds to exit Raksystems in sale to Trill Impact
New majority owner will seek to expand the Finnish green building services specialist across Europe
Latest News
Silver Investment forms continuation vehicle for PTF
Selling investors have made returns of 6x their original investment in the precision parts producer
Synthesis Capital holds USD 300m final close for debut fund
Costa Yiannoulis and David Welch spoke to Unquote about the food technology and alternative protein VC's strategy
Goldman Sachs AM beats sponsors to buy Norgine
Buyer's PE arm competed with Bain and Cinven in the auction second round
Pantheon, ICG appoint new ESG heads
Eimear Palmer joins Pantheon from ICG, which has poached Elsa Palanza from Barclays